Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Hang He

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5481-8794; OpenAlex author ID A5036669518. Sources: OpenAlex.

Their work

Papers
16 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
36
Papers, trials and grants by year

2013: 2 papers · 2014: 2 papers · 2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: 2 papers · 2023: none · 2024: 3 papers · 2025: 2 papers

Papers 16

  1. Periarterial divestment for borderline and locally advanced pancreatic cancer: An analysis of 125 cases in a single center. Co-author DOI 10.1016/j.surg.2025.109412↗
  2. The development and validation of biomarkers-based scoring systems for predicting early recurrence in patients with borderline resectable pancreatic cancer und… Co-author DOI 10.21037/gs-2024-500↗
  3. Roflumilast inhibits tumor growth and migration in STK11/LKB1 deficient pancreatic cancer. Co-author DOI 10.1038/s41420-024-01890-y↗
  4. Recurrence scoring system predicting early recurrence for patients with pancreatic ductal adenocarcinoma undergoing pancreatectomy and portomesenteric vein res… Co-author DOI 10.4240/wjgs.v16.i10.3185↗
  5. Postoperative serum tumor markers-based nomogram predicting early recurrence for patients undergoing radical resections of pancreatic ductal adenocarcinoma. Co-author DOI 10.4240/wjgs.v16.i10.3211↗
  6. Identification of MARCO and PCSK6 As Key Genes Promoting Hepatic Metastasis in Pancreatic Cancer via Bioinformatics Analysis Co-author DOI 10.21203/rs.3.rs-1303593/v1↗
  7. Identification of Genes Associated with Liver Metastasis in Pancreatic Cancer Reveals PCSK6 as a Crucial Mediator. Co-author DOI 10.3390/cancers15010241↗
  8. Blood-based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Pancreatic Cancer and its Value to Guide Clinical Treatment. Co-author DOI 10.7150/jca.43087↗
  9. Genome-Wide Analysis Identified a Number of Dysregulated Long Noncoding RNA (lncRNA) in Human Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1177/1533034617748429↗
  10. Magnetic mesoporous nanospheres anchored with LyP-1 as an efficient pancreatic cancer probe. Co-author DOI 10.1016/j.biomaterials.2016.11.006↗
  11. Application of Deuteporfin in the Metastatic Lymph Node Mapping of Pancreatic Cancer: An in vivo Study. Co-author DOI 10.1111/php.12574↗
  12. An in vitro and in vivo study of gemcitabine-loaded albumin nanoparticles in a pancreatic cancer cell line. Co-author DOI 10.2147/ijn.s93835↗
  13. Magnetic graphene-based nanotheranostic agent for dual-modality mapping guided photothermal therapy in regional lymph nodal metastasis of pancreatic cancer. Co-author DOI 10.1016/j.biomaterials.2014.07.064↗
  14. MicroRNA-218 inhibits cell invasion and migration of pancreatic cancer via regulating ROBO1. Co-author DOI 10.4161/cbt.29706↗
  15. Elevated expression of tumor miR-222 in pancreatic cancer is associated with Ki67 and poor prognosis. First author DOI 10.1007/s12032-013-0700-y↗
  16. The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer. Co-author DOI 10.3892/or.2013.2516↗

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chen Jin · 11 shared papers, 2013–2025 · strength 1.41
  2. Feng Yang · 8 shared papers, 2013–2025 · strength 1.04
  3. Yongjian Jiang · 7 shared papers, 2013–2025 · strength 0.77
  4. Deliang Fu · 8 shared papers, 2013–2024 · strength 0.74
  5. De-Liang Fu · 2 shared papers, 2024–2025 · strength 0.53
  6. Ji Li · 4 shared papers, 2013–2024 · strength 0.42
  7. Minrui Liang · 2 shared papers, 2013–2022 · strength 0.36
  8. Deliang Fu · 2 shared papers, 2016–2025 · strength 0.36
  9. Di Yang · 7 shared papers, 2013–2018 · strength 0.35
  10. Lie Yao · 5 shared papers, 2013–2020 · strength 0.32
  11. Ji Li · 1 shared paper, 2025 · strength 0.30
  12. Hai Yang · 2 shared papers, 2022–2024 · strength 0.30
  13. Nathalie Britzen‐Laurent · 2 shared papers, 2022–2024 · strength 0.30
  14. Robert Grützmann · 2 shared papers, 2022–2024 · strength 0.30
  15. Christian P. Pilarsky · 2 shared papers, 2022–2024 · strength 0.30
  16. Hengchao Li · 3 shared papers, 2015–2020 · strength 0.20
  17. Sijie Hao · 3 shared papers, 2013–2018 · strength 0.16
  18. Yanxi Lu · 1 shared paper, 2024 · strength 0.15
  19. Jinping Zhang · 1 shared paper, 2024 · strength 0.15
  20. Duo Yun · 1 shared paper, 2024 · strength 0.15
  21. Bin Lan · 1 shared paper, 2024 · strength 0.15
  22. Eva Lentsch · 1 shared paper, 2024 · strength 0.15
  23. Marc P. Stemmler · 1 shared paper, 2024 · strength 0.15
  24. Shuman Zhang · 1 shared paper, 2024 · strength 0.15
  25. Hao Yang · 1 shared paper, 2024 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.